PRTN3 and rheumatoid arthritis: Patients with >20 pack years demonstrated significantly increased risk of ACPA positive RA compared to patients who had never smoked (158/200 (79%) vs. 146/235 (62%), OR (95% CI) 2.3(1.5–3.6), p < 0.0001).